Slope and LabConnect Enhance Clinical Trial Efficiency via API
API integration drives adoption among multiple sponsors, unifying data exchange across the biospecimen lifecycle for complex clinical trials.
Slope, a pioneering platform for managing biospecimens and lab kits, has made significant strides in collaboration with LabConnect, a leader in global central laboratory solutions. This partnership has opened new horizons for clinical trials, integrating crucial technologies that boost operational efficiency and precision.
Impact of API Integration on Clinical Trials
The integration of Application Programming Interfaces (APIs) marks a revolutionary advancement in the clinical trial ecosystem. By merging Slope’s site-facing platform with LabConnect's laboratory information management system (LIMS), there is greater synergy among research sites, sponsors, and laboratories. This technology simplifies lab kit ordering, inventory management, sample shipment, and data exchange essential for seamless trial execution.
Revolutionizing Data Management
Through the API integration, many joint customers began utilizing the combined platform late in 2025, allowing for a cohesive data exchange system that benefits clinical operations. An impressive transition from mere announcements to real-world implementations showcases the potential for enhanced efficiency across various therapeutic areas. Slope’s Chief Product and Technology Officer, Jim Munz, emphasized that the impact of this integration enables sponsors to run trials more smoothly and effectively.
Enhancing Site Inventory Control
One major advantage of the Slope and LabConnect integration is its ability to provide sponsors with enhanced visibility into inventory management. Automated lab kit resupply orders initiated within LabConnect flow directly into Slope's system, allowing for real-time tracking of deliveries. This digitization minimizes the need for manual updates, reduces errors, and streamlines operations significantly.
Improving Site Workflow and Sample Processing
By leveraging Slope’s guided workflows for sample collection and handling, sites can shift away from traditional lab manuals. The integrated platform supports seamless transfer and capture of sample and subject metadata, bridging the gap between site-level activities and laboratory management. The collaborative effort allows laboratory personnel to pre-accession samples based on up-to-date information, leading to decreased discrepancies and fewer delays during sample analysis.
Future Enhancements to the Integration
The roadmap ahead for the Slope + LabConnect integration looks promising, with plans to introduce even further enhancements to sample tracking workflows. These upcoming improvements will facilitate lab-to-lab transfers and strengthen overall biospecimen management. This progressive development is aimed at ensuring sponsors can maintain a holistic view of their biospecimen operations.
About Slope
Slope stands out in the clinical research landscape as the only vendor-agnostic platform for biospecimen and clinical inventory management. It boasts a network of over 2,200 sites across more than 23 countries, facilitating remarkable efficiencies, including a 71% reduction in lab kit waste and a 98% site adoption rate on sponsor contracts. Slope’s technology integrates every aspect of the biospecimen lifecycle, effectively addressing inefficiencies that can slow down research and inflate costs.
About LabConnect
LabConnect redefines the paradigm of central laboratory services through its technology-driven approach. The company offers a decentralized network model, providing access to an extensive range of testing services that are supported by advanced data management and consulting. This strategy enhances scalability and operational efficiency, allowing for faster development of innovative therapies with improved precision and flexibility.
Frequently Asked Questions
What are the key benefits of the Slope and LabConnect partnership?
The partnership leads to enhanced operational efficiency, better data management, and improved site inventory control through API integration.
How does the API integration improve clinical trial processes?
It allows seamless data exchange and inventory management, which reduces manual errors and streamlines sample handling.
What technologies do Slope and LabConnect utilize?
Slope provides a vendor-agnostic platform for biospecimen management, while LabConnect offers a globally recognized laboratory information management system (LIMS).
Who benefits from the Slope + LabConnect integration?
Sponsors, research sites, and clinical trial teams benefit significantly through increased efficiency and reduced costs associated with trial management.
What future improvements are expected from this integration?
Further enhancements to sample tracking capabilities and lab-to-lab transfer functionalities are planned in the near future.
